Taishi Onodera

6PUBLICATIONS
59CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsInnate immunityMedical infection agents (incl. prions)Gene and molecular therapyGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 21, 2024
Repeated Omicron exposures redirect SARS-CoV-2-specific memory B cell evolution toward the latest variants.

Ryutaro Kotaki, Saya Moriyama, Shintaro Oishi

|Jun 14, 2023
CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes.

Taishi Onodera, Nicolas Sax, Takashi Sato

|Jan 08, 2023
Direct Inhibition of SARS-CoV-2 Spike Protein by Peracetic Acid.

Yuichiro Yamamoto, Yoshio Nakano, Mana Murae

|Aug 26, 2022
Neutralizing mAbs against SFTS Virus Gn Protein Show Strong Therapeutic Effects in an SFTS Animal Model.

Masayuki Shimojima, Satoko Sugimoto, Kunihiko Umekita

|Oct 14, 2021
Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patients.

Xiuyuan Lu, Yuki Hosono, Masamichi Nagae

|Oct 08, 2021
Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses.

Ryo Shinnakasu, Shuhei Sakakibara, Hiromi Yamamoto

Pageof 1